0001415889-23-007372.txt : 20230504 0001415889-23-007372.hdr.sgml : 20230504 20230504183356 ACCESSION NUMBER: 0001415889-23-007372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230502 FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smaldone Alsup Laurie CENTRAL INDEX KEY: 0001589602 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 23890571 MAIL ADDRESS: STREET 1: 190 WOOSAMONSA RD CITY: PENNINGTON STATE: NJ ZIP: 08534 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-05042023_100550.xml X0407 4 2023-05-02 0001583107 Theravance Biopharma, Inc. TBPH 0001589602 Smaldone Alsup Laurie C/O THERAVANCE BIOPHARMA US, INC 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 true false false false 0 Ordinary Shares 2023-05-02 4 A 0 9132 0 A 53794 D Share Option (Right to Buy) 10.95 2023-05-02 4 A 0 22044 0 A 2033-05-01 Ordinary Shares 22044 22044 D This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. /s/ Brett A. Grimaud, Attorney-in-Fact 2023-05-04